Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
The Journal of Infectious Diseases
|
January 7, 1998
A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection
J A Bartlett, P S Berry, K W Bockman, et al.
AIDS Research and Human Retroviruses
|
May 19, 2006
Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2
T Melby, P Sista, R DeMasi, et al.
The Journal of Trauma
|
April 1, 1997
Blunt injury of the abdominal aorta: a review
S M Roth, J R Wheeler, R T Gregory, et al.
Journal of Viral Hepatitis
|
October 30, 2016
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis
M El Raziky, M Gamil, M K Ashour, et al.
Gut
|
November 9, 2013
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
M Colombo, I Fernández, D Abdurakhmanov, et al.
Statistics in Medicine
|
November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop
J M Albert, J P Ioannidis, P Reichelderfer, et al.
Physical Review Letters
|
October 10, 2006
Measurement of deeply virtual compton scattering with a polarized-proton target
S Chen, H Avakian, V D Burkert, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
The Journal of Infectious Diseases
|
January 7, 1998
A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection
J A Bartlett, P S Berry, K W Bockman, et al.
AIDS Research and Human Retroviruses
|
May 19, 2006
Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2
T Melby, P Sista, R DeMasi, et al.
The Journal of Trauma
|
April 1, 1997
Blunt injury of the abdominal aorta: a review
S M Roth, J R Wheeler, R T Gregory, et al.
Journal of Viral Hepatitis
|
October 30, 2016
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis
M El Raziky, M Gamil, M K Ashour, et al.
Gut
|
November 9, 2013
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
M Colombo, I Fernández, D Abdurakhmanov, et al.
Statistics in Medicine
|
November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop
J M Albert, J P Ioannidis, P Reichelderfer, et al.
Physical Review Letters
|
October 10, 2006
Measurement of deeply virtual compton scattering with a polarized-proton target
S Chen, H Avakian, V D Burkert, et al.
Page
of 3